HIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital

J Int Assoc Provid AIDS Care. 2017 Jan/Feb;16(1):37-41. doi: 10.1177/2325957415614651. Epub 2016 Jul 7.

Abstract

Objectives: We sought to characterize recent cases of toxic epidermal necrolysis (TEN) in HIV-infected patients at San Francisco General Hospital (SFGH), a large HIV referral center.

Methods: This was a retrospective analysis of HIV-infected patients diagnosed with TEN from January 2001 to May 2014 at SFGH.

Results: Ten cases of TEN were identified, 50% of which occurred in HIV-infected individuals. Among the HIV-associated cases, causative agents were trimethoprim-sulfamethoxazole (TMP-SMX; n = 2), atovaquone, clindamycin, and fluconazole. No antiretroviral agents were implicated.

Conclusion: Although limited by small sample size, our experience is reflective of the well-recognized increased incidence of TEN in HIV-positive patients and suggests that antimicrobial agents, particularly TMP-SMX, are the most common causative agents in this population. As 3 of the 5 HIV-associated TEN cases were caused by potentially inappropriate or unnecessary use of antibiotics, our experience highlights the importance of judicious use of systemic medications in populations susceptible to severe adverse drug reactions.

Keywords: AIDS; HIV; TEN; drug reaction; toxic epidermal necrolysis.

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / prevention & control
  • Adult
  • Aged
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis / adverse effects
  • Female
  • HIV Infections* / complications
  • HIV Infections* / epidemiology
  • Hospitals, General
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • San Francisco / epidemiology
  • Stevens-Johnson Syndrome* / complications
  • Stevens-Johnson Syndrome* / epidemiology
  • Stevens-Johnson Syndrome* / etiology
  • Trimethoprim, Sulfamethoxazole Drug Combination / adverse effects
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Trimethoprim, Sulfamethoxazole Drug Combination